InnoCare Pharma Limited ( INCPF) - Key Metrics
INCPF Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q1 | ? | ? | ? | ? |
| 2025Q4 | $0.70 | $0.40 | $0.12 | $0.10 |
| 2025Q3 | $0.22 | -$0.02 | $0 | -$0.01 |
| 2025Q2 | $0.29 | -$0.04 | -$0.10 | -$0.11 |
| 2025Q1 | $0.21 | $0.01 | $0.03 | $0.02 |
INCPF Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q1 | ? | ? |
| 2025Q4 | ? | 6.99 |
| 2025Q3 | ? | -221.87 |
| 2025Q2 | -17.53% | -75.36 |
| 2025Q1 | 45.50% | 213.03 |
INCPF Free Cash Flow Yield and Dividend Yield
| Date | Free Cash Flow Yield | Dividend Yield |
|---|---|---|
| 2026Q1 | -0.02% | ? |
| 2025Q4 | 0.70% | ? |
| 2025Q3 | -0.04% | ? |
| 2025Q2 | -0.45% | 0.06% |
| 2025Q1 | 0.10% | 0.05% |
INCPF
Price: $1.55
52 week price:
Payout Ratio Range:
Earnings Per Share: 0.06 USD
P/E Ratio: 25.83
Exchange: PNK
Sector: Healthcare
Industry: Biotechnology
Market Capitalization: 2.3 billion